APA (7th ed.) Citation

Dietrich, N., Kolibabka, M., Bugert, P., Kaiser, U., Lin, J., Fleming, T., . . . Hammes, H. (2016). The DPP4 inhibitor linagliptin protects from experimental diabetic retinopathy. PLOS ONE, 11(12), . https://doi.org/10.1371/journal.pone.0167853

Chicago Style (17th ed.) Citation

Dietrich, Nadine, Matthias Kolibabka, Petra Bugert, Ulrike Kaiser, Jihong Lin, Thomas Fleming, Michael Morcos, Andrea Schlotterer, and Hans-Peter Hammes. "The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy." PLOS ONE 11, no. 12 (2016). https://doi.org/10.1371/journal.pone.0167853.

MLA (9th ed.) Citation

Dietrich, Nadine, et al. "The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy." PLOS ONE, vol. 11, no. 12, 2016, https://doi.org/10.1371/journal.pone.0167853.